Huntington’s disease R&D is regaining ground after several disappointments

Researchers are finally making headway in the search for Huntington’s disease treatments after a series of demoralizing setbacks. Three new drugs with the potential to slow the progression of the devastating inherited brain disorder have chalked up clinical wins, including medicines from UniQure, Prilenia, Wave, Roche and Ionis.